Takayuki Hashimoto
Papers
1
Total Citations
10
H-Index
1
About
Takayuki Hashimoto is a leading figure in pediatric radiation oncology, with a specialized focus on proton therapy for central nervous system (CNS) tumors. His key research centers on advancing craniospinal irradiation techniques, particularly through the development and clinical validation of intensity-modulated proton therapy (ipCSI). Hashimoto’s major contribution is the pioneering of a novel ipCSI system that integrates gantry-mounted orthogonal X-ray imagers with a robotic six-degrees-of-freedom patient table, enabling unprecedented precision in treating medulloblastomas and germ cell tumors in children, adolescents, and young adults. His landmark 2019 study, cited 10 times, demonstrated the clinical feasibility and dosimetric benefits of this approach, showing improved target coverage while reducing radiation exposure to critical organs. This work has helped establish proton therapy as a safer, more effective standard for young patients with CNS malignancies. Hashimoto’s achievements are particularly notable for addressing the technical challenges of treating large fields in pediatric populations, where minimizing long-term side effects is paramount. His research continues to shape the evolution of precision radiotherapy, offering hope for better outcomes and quality of life in young cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1